Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Perić Balja, Melita"'
Autor:
Čeprnja, Toni, Tomić, Snježana, Perić Balja, Melita, Marušić, Zlatko, Blažićević, Valerija, Spagnoli, Giulio Cesare, Juretić, Antonio, Čapkun, Vesna, Vuger, Ana Tečić, Pogorelić, Zenon, Mrklić, Ivana
Publikováno v:
International Journal of Molecular Sciences; Apr2024, Vol. 25 Issue 8, p4513, 12p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Terlević, Robert, Perić Balja, Melita, Tomas, Davor, Skenderi, Faruk, Krušlin, Božo, Vranic, Semir, Demirović, Alma
Publikováno v:
In Annals of Diagnostic Pathology February 2019 38:62-66
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tečić Vuger, Ana, Perić Balja, Melita, Jakšić, Petra, Linarić, Petra, Pavlović Mavić, Mirjana, Vazdar, Ljubica, Šeparović, Robert
Neoadjuvant, i.e. preoperative, systemic antineoplastic treatment (NAT), in patients with breast cancer enables in vivo monitoring of tumor response to applied therapy, tailoring treatment in real –time accordingly, sparing surgical procedures, bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::de798104747bb8dff63770095b3df808
https://www.bib.irb.hr/1260825
https://www.bib.irb.hr/1260825
Autor:
Alfier, Gabriela, Stepan Giljevic, Jasminka, Milas, Ivan, Perić Balja, Melita, Bolanča Čulo, Karolina
Castleman disease (CD) is a rare B-cell lymphoproliferative disorder of unknown etiology characterized by benign lymphoid follicular hyperplasia and capillary proliferation. CD can be divided histologically into four different variants: hyaline-vascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::3d05ce86fca1309a0e267cad9efb3149
https://doi.org/10.25083/2559-5555
https://doi.org/10.25083/2559-5555
Autor:
Perić Balja, Melita
Do pojave ciljane anti-HER2 terapije, HER2 pozitivni karcinomi dojke (HER2+ KD) imali su najlošiju prognozu, a uvođenjem neoadjuvantne anti-HER2 terapije (NAT) dodatno je poboljšano preživljenje bolesnica. Unatoč uspjesima NAT, dio bolesnica pok
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8b1ef3782a0412e37404fda54583c53d
https://www.bib.irb.hr/1260341
https://www.bib.irb.hr/1260341
Breast leiomyoma is an exceedingly rare benign mesenchymal tumor that accounts for less than 1% of all breast neoplasms, and its presence in the mammary parenchyma is the rarest location with fewer than 30 cases reported so far in literature. The dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::008a2b656243ed415cedc6c9feaa715b
https://www.bib.irb.hr/1260804
https://www.bib.irb.hr/1260804
Autor:
Cesarec Augustinović, Sanja, Ramić, Snježana, Kirigin, Monica Stephany, Sesar, Patricija, Puhalo, Ana, Perić Balja, Melita
As defined by the National Cancer Institute, rare cancer is cancer that occurs in fewer than 15 out of 100, 000 people each year. According to the World Health Organization (WHO) the term “Invasive breast carcinoma” (IBC) refers to a large and he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::ea3075cedb80b557d878de10e44dda01
https://www.bib.irb.hr/1260342
https://www.bib.irb.hr/1260342
Neoadjuvant chemotherapy (NAC) is used as a systematic pre-surgery approach to treat locally advanced or inoperable breast cancer. Following NAC, pathologists estimate the response to treatment based on tumor size and cellularity, number of positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::195072b41ce6196e1d7e956a21638e7e
https://www.bib.irb.hr/1260344
https://www.bib.irb.hr/1260344